LifeMD is linking arms with NovoCare Pharmacy to offer Wegovy (semaglutide) at $499 monthly for cash-pay patients through its virtual care platform. This move comes as several telehealth companies race to simplify access to FDA-approved weight loss medications following the end of nationwide shortages. “By embedding direct access to Wegovy via NovoCare Pharmacy into our platform, we’re enhancing the patient experience, expanding access to a critical medication, and reinforcing LifeMD’s position as a leader in delivering comprehensive, technology-enabled obesity care,” said Justin Schreiber, Chairman and CEO of LifeMD. The service integrates virtual consultations, lab testing, diet and lifestyle support within … Continue reading LifeMD’s NovoCare Offers $499 Wegovy—Telehealth GLP-1 Scripts Jump 10% as U.S. Obesity Tops 40%